Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders
Details for Australian Patent Application No. 2002303061 (hide)
International Classifications
Event Publications
12 December 2002 Complete Application Filed
Priority application(s): 60/294,102 29.05.01 US; 0101660-9 11.05.01 SE; 60/294,132 29.05.01 US; 0101659-1 11.05.01 SE; 0101958-7 05.06.01 SE
1 May 2003 Application Open to Public Inspection
Published as AU-B-2002303061
10 January 2008 Alteration of Name
The name of the applicant has been altered to Biovitrum AB (publ)
29 January 2009 Application Accepted
Published as AU-B-2002303061
28 May 2009 Standard Patent Sealed
2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002303062-METHOD AND DEVICE FOR CALCINATION
2002303060-METHOD FOR LASER DRILLING IN MATERIALS USED FOR PRODUCTION OF PRINTED CIRCUITS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser